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Abstract
Signaling through the heterotrimeric G protein, G12, via Rho induces a striking increase in breast cancer cell invasion. In this
study, evidence is provided that the c-Jun NH2-terminal kinase (JNK) is a key downstream effector of G12 on this pathway.
Expression of constitutively-active Ga12 or activation of G12 signaling by thrombin leads to increased JNK and c-Jun
phosphorylation. Pharmacologic inhibition of JNK or knockdown of JNK expression by siRNA significantly decreases G12-
induced JNK activation as well as the ability of breast cancer cells to invade a reconstituted basement membrane.
Furthermore, expression of dominant-negative Rho or treatment of cells with an inhibitor of the Rho kinase, ROCK, reduces
G12-induced JNK and c-Jun activation, and ROCK inhibitor treatment also inhibits G12-induced cellular invasion. JNK
knockdown or ROCK inhibitor treatment has no effect on activation of Rho by G12. Taken together, our data indicate that
JNK activation is required for G12-induced invasion of breast cancer cells and that JNK is downstream of Rho and ROCK on
this pathway. This study implicates a G12-stimulated mitogen-activated protein kinase cascade in cancer cell invasion, and
supports a role for JNK in cancer progression.
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Introduction
Heterotrimeric guanine nucleotide-binding regulatory proteins
(G proteins) transduce extracellular signals from heptahelical G
protein-coupled receptors to intracellular effectors, thus mediating
numerous cellular responses [1,2]. G proteins are classified into
four subfamilies based on the sequence identity of their alpha
subunits: Gs, Gi, Gq and G12. The G12 subfamily members,
Ga12 and Ga13, are the most potent transforming alpha subunits
known thus far [3,4]. In fact, Ga12 was identified as the
transforming oncogene in a study using an expression cloning
method to identify putative oncogenes of soft tissue sarcoma [5].
Subsequent work has implicated Ga12 and Ga13 in various
physiological and pathophysiological processes such as cell growth
and proliferation, cytoskeleton rearrangement, regulation of cell
polarity, cellular adhesion, migration and metastasis [6–9].
Activation of G12 proteins impacts on several signaling
pathways including mitogen-activated protein kinase (MAPK)
cascades, where they can coordinate the stimulation and/or
inhibition of MAPKs [10–12]. G12-induced regulation of MAPK
signaling pathways appears to be primarily mediated by the Rho
family of monomeric GTPases, which are the most extensively
characterized downstream effectors of G12 proteins [3,12]. Ga12
and Ga13 stimulate JNK activity [12–14]; a major outcome of
JNK activation in cells is the phosphorylation of the transcription
factor c-Jun, leading to increased transcription of genes involved in
proliferation and survival, cell motility and invasion, among others
[15]. Thus, some of the biological consequences of Ga12/13
activation could potentially be due to an impact on c-Jun activity
[16–18].
We recently reported a role for the G12 subfamily of G proteins
in cancer invasion and metastasis [19,20]. Stimulation of G12
signaling induced invasion of breast cancer cells in vitro in a Rho-
dependent manner, and inhibition of G12 signaling significantly
reduced metastatic dissemination of breast cancer cells in vivo [19].
In the current study, we sought to examine if JNK was a
downstream effector on the pathway stimulated by G12 that leads
to breast cancer cell invasion. As expected, G12 signaling
increased JNK phosphorylation in breast cancer cells. Important-
ly, we found that activation of JNK is required for breast cancer
cell invasion induced by activated Ga12, indicating that JNK is an
important downstream mediator of activated G12 in these cells.
These findings have implications for understanding the molecular
events contributing to metastatic dissemination of tumor cells.
Materials and Methods
Cell lines and reagents
The MDA-MB-231 cell line (obtained from American Type
Culture Collection) and the 4T1 cell line (a generous gift from
Fred Miller, Barbara Ann Karmanos Cancer Center, Detroit) [19]
were maintained in DMEM (Mediatech Inc, Manassas, VA)
supplemented with 10% fetal bovine serum (Atlas Biologicals, Fort
Collins, CO). The JNK 1/2 siRNA [21] was synthesized by
Integrated DNA Technologies, Inc. (Coralville, IA). Oligofecta-
mine reagent was from Invitrogen (Carlsbad, CA). The JNK
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inhibitor SP600125 and ROCK inhibitor Y-27632 were pur-
chased from Calbiochem (San Diego, CA). Recombinant human
thrombin was from Enzyme Research Laboratories (South Bend,
IN). Growth-factor reduced Matrigel was from BD Biosciences
(Bedford, MA) and fibronectin from human plasma was from
Sigma (St. Louis, Mo). cDNAs encoding Ga12QL, HA-RGS2
(both from University of Missouri cDNA Resource Center, Rolla,
MO) and myc-p115RGS (a gift of Tohru Kozasa, University of
Illinois, Chicago) were used to create recombinant adenoviruses as
described previously [19]. Dominant-negative RhoA adenovirus
was a gift from Terete Borra´s (University of North Carolina,
Chapel Hill). The pGEX-2T plasmid containing a GST fusion to
the rhotekin RhoA-binding domain (GST-RBD) was kindly
provided by Robert Lefkowitz (this institution). Phospho-SAPK/
JNK (Thr183/Thr185) antibody was from Cell Signaling Technol-
ogy, Inc (Beverly, MA). Antibodies to Ga12, phospho-c-Jun, JNK,
RhoA, a-tubulin were purchased from Santa Cruz Biotechnology
(Santa Cruz, CA). Anti-c-myc was from Zymed Laboratories, (San
Francisco, CA) and anti-HA was from Roche Applied Science
(Indianapolis, IN). Protease inhibitors were purchased from Sigma
and Roche Applied Science.
JNK activation assay
MDA-MB-231 cells were seeded at a density of 200,000 per well
in 6-well plates and infected with the indicated adenovirus for
,6 h. For JNK knockdown experiments, cells were seeded at
100,000 per well and transfected with siRNA for 70–72 h before
infection. 260 pmol (20 pmol/ml) of control or JNK siRNA was
transfected per well using Oligofectamine reagent. Cells were
starved for ,2–20 h before lysis in JNK activation buffer [22].
4T1 cells were infected with the indicated adenovirus for 18–19 h
and starved for ,9 h before lysis. For inhibiting JNK or ROCK,
cells were treated with their respective inhibitors, 20 mM
SP600125 or 10 mM Y-27632, for 2 h before lysis. Cells were
lysed for 10 min and lysates prepared by centrifugation at
160006g for 5 min at 4uC. Equal amounts of total protein from
lysates were separated by SDS-PAGE and subjected to immuno-
blot analysis to detect levels of phospho-JNK and phospho-c-Jun.
Cell invasion assay
For invasion assays, transwell chambers (8 mm pore size,
polycarbonate filters, 6.5 mm diameter; Costar) were coated with
50 mg growth-factor-reduced Matrigel [19]. MDA-MB-231 cells
that had been starved for 18–20 h, or 4T1 cells that had been
starved for 8 h, were suspended in starvation media (DMEM
containing 0.1% BSA), and 46104 cells were plated on top of the
Matrigel in the upper chamber with or without agonists as
indicated. Cells were allowed to invade Matrigel towards 5 mg/ml
fibronectin in starvation media or towards 3% FBS. After 24 h,
cells in the upper chamber that did not invade were removed by
swiping with cotton swabs. The transwell membranes were then
stained using the Hema3 staining kit (Fisher Scientific) and cells on
the underside of the membranes that had invaded the Matrigel
were counted under a Nikon TS100 microscope. Four high-
powered fields were counted for each membrane.
Rho activation assay
Cells were seeded at a density of 200,000 (or 100,000 for siRNA
transfections) per well in 6-well plates. Cells were infected with the
indicated adenovirus for 6–7 h, and starved for 18 h before lysis.
Rho activation assays were performed as described previously
[22]. Rho-GTP in cell lysates was precipitated using the activated
Rho-binding domain of rhotekin and detected by separation on
SDS-PAGE followed by immunoblot analysis.
Rhodamine-phalloidin staining
MDA-MB-231 cells were plated on coverslips. After starvation
for ,18 h, cells were washed in PBS, fixed in 4% paraformalde-
hyde and permeabilized in 0.1% Triton X-100. Cells were blocked
in 5% serum and incubated with rhodamine-phalloidin for 1 h at
room temperature. The coverslips were mounted on glass slides
and images acquired on a Zeiss Axio Imager fluorescence
microscope using the MetaMorph 7.5 software. Fluorescence
intensities were quantified using the MetaMorph 7.5 software.
Statistical analysis
Data were analyzed using GraphPad Prism v4 (GraphPad
Software Inc.). Data are presented as mean6 SEM and compared
by one-way ANOVA, followed by Tukey’s multiple comparison
test to obtain P values. A probability of p,0.05 was considered
significant.
Results
G12 signaling activates JNK and promotes breast cancer
cell invasion
As we previously reported, ectopic expression of activated Ga12
(Ga12QL) in MDA-MB-231 breast cancer cells leads to the
activation of JNK [22]; see also Figure 1A. Here, we studied this
process both by examining c-Jun phosphorylation as well as JNK
phosphorylation to confirm an increase in JNK activity. The JNK
protein is encoded by three genes (jnk1, jnk2 and jnk3) [23]. JNK1
and JNK2 proteins are ubiquitously expressed while JNK3
expression is restricted to brain, heart and testis. Each JNK is
expressed as a short form (46 kDa) and a long form (54 kDa); both
forms are detected by the phospho-JNK antibody used in this
study. As shown in Figure 1A, expression of Ga12QL induces
JNK phosphorylation (lane 5) and this could be rapidly and
efficiently blocked by treating cells with the pharmacologic
inhibitor of JNK phosphorylation, SP600125. Since it has been
reported that SP600125 may not be a specific inhibitor of JNK
activation [24], we also employed siRNA-mediated silencing of
JNK expression. JNK knockdown of .90% was accompanied by
a complete loss of Ga12QL-stimulated c-Jun phosphorylation in
MDA-MB-231 cells (Figure 1B), but did not affect proliferation or
viability of MDA-MB-231 cells as assessed by an MTS assay (data
not shown). Hence, in addition to an impact on JNK activation,
expression of Ga12QL induces elevated levels of c-Jun phosphor-
ylation, and c-Jun activation resulting from the introduction of
activated Ga12 is blocked both by pharmacologic and siRNA-
mediated inhibition of JNK activation (Figures 1A, B).
JNK activation has been implicated in promoting invasion of
transformed fibroblasts and of several cancer cell lines [25–28].
Since expression of Ga12QL in MDA-MB-231 cells induces their
invasion in vitro [19], we sought to determine if JNK might be a
downstream effector of G12 signaling leading to invasion of breast
cancer cells. Indeed, expression of Ga12QL in MDA-MB-231
cells induced an approximately six-fold increase in cell invasion
through Matrigel, and inhibition of JNK activation by SP600125
resulted in a nearly 70% decrease in Ga12QL-stimulated cell
invasion (Figure 2A). Furthermore, while Ga12QL induced an
eight-fold increase in invasion of control cells, blocking JNK
expression by siRNA-mediated knockdown caused a significant
(50–60%) decrease in their ability to invade Matrigel in response
to introduction of activated Ga12 (Figure 2B). There was no effect
of silencing JNK expression on the invasion of control cells,
demonstrating that this effect is specific to Ga12QL-induced
invasion. These data strongly implicate JNK activation as being
JNK and G12-Induced Invasion
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important in breast cancer cell invasion induced by activated
Ga12.
G12 activates a ROCK to JNK signaling axis in breast
cancer cells
Since activation of Rho is required for G12 to induce invasion
in breast cancer cells [19], we examined the possibility that JNK is
downstream of Rho on this signaling pathway. Expression of
dominant-negative RhoA (DN RhoA) in MDA-MB-231 cells
significantly inhibited Ga12QL-indued JNK as well as c-Jun
phosphorylation (Figure 3A), indicating that JNK is indeed
activated downstream of Rho. Furthermore, stimulation of
endogenous G12 signaling by thrombin, which activates the
G12-coupled protease-activated receptor (PAR-1) [29], led to JNK
and c-Jun activation in breast cancer cells in a manner that was
inhibited by expression of DN RhoA (Figure 3A).
The best characterized effector of activated Rho is the Rho
kinase, ROCK, which controls actin polymerization and leads to
serum response factor (SRF) activation [30,31]. Additionally,
previous studies have shown that Rho can activate JNK through
ROCK [32–34]. When treated with the ROCK inhibitor Y-
27632, MDA-MB-231 cells expressing Ga12QL show a significant
decrease in the levels of JNK and c-Jun phosphorylation as
compared to untreated cells (Figure 3B). In addition, treatment of
cells with the ROCK inhibitor decreases G12-induced cell
invasion by about 70% (Figure 3C).
Treatment of cells with the ROCK inhibitor did not affect
Ga12QL-stimulated Rho activation (data not shown). To assess
whether Rho activation by G12 was affected by JNK inhibition,
i.e. whether Rho is upstream of ROCK and JNK as would be
expected, we compared the levels of active Rho in lysates from
cells in which JNK was inhibited either pharmacologically or by
RNAi-mediated suppression. Comparison of Rho-GTP levels in
cells expressing Ga12QL that had been transfected with control or
JNK siRNA clearly demonstrated that JNK knockdown did not
affect activation of Rho by Ga12QL (Figure 4A). Taken together,
these data suggest that JNK is activated downstream of the Rho-
ROCK axis in the signaling pathway triggered by G12 that
promotes invasion of breast cancer cells. Interestingly, Ga12QL-
stimulated Rho-GTP levels appear to be higher in cells in which
JNK expression has been knocked down by siRNA compared to
that in control cells (Figure 4A). When Rho-GTP levels were
quantified and analyzed as a percentage of activated Rho to total
Rho in each sample (Figure 4B), silencing JNK expression was
indeed determined to elicit a significant increase in Rho activation
status. This finding suggests the possible existence of a feedback
signaling pathway in which reduction of JNK levels leads to
increased Rho activation.
Additional evidence in support of a JNK-Rho feedback
mechanism was provided by the finding that rhodamine-phalloidin
staining of the actin cytoskeleton was increased in cells in which
JNK expression was reduced by siRNA treatment (Figure 4C, D). It
is well-documented that activation of Rho leads to stress fiber
formation in several cell types [35]. Further, G12 proteins have been
shown to stimulate stress fiber formation in a Rho-dependent
manner in fibroblasts [36]. Under normal culture conditions, MDA-
MB-231 breast cancer cells exhibit few or no stress fibers (Figure 4C,
panel a). Ga12QL expression induced stress fiber assembly in these
cells as is evident from the intense rhodamine-phalloidin staining
compared to control cells (Figure 4C, panel b). As we previously
reported [22], expression of Ga12QL in MDA-MB-231 breast
cancer cells also caused a Rho-dependent change from a flattened to
a rounded morphology (Figure 4C, panel b). Interestingly, there
appears to be a distinct increase in stress fiber formation in
Ga12QL-expressing as well as control (GFP) cells transfected with
JNK siRNA (Figure 4C, panels a, b, d, e).
Figure 1. Ga12QL activates JNK in breast cancer cells. MDA-MB-231 cells were infected with GFP (control) or Ga12QL adenovirus for 6–7 h. (A)
Cells were starved for 2 h and then treated for the indicated time with JNK inhibitor SP600125 (20 mM) prior to lysis in JNK activation buffer and
processing for analysis (see Materials and Methods). (B) Cells were transfected with JNK siRNA or control (luc) siRNA for ,72 h prior to infection with
adenovirus as in (A). Cells were starved for 18 h before being lysed. For both panels, equal amounts of total protein in lysates were subjected to SDS-
PAGE and immunoblot analysis to assess levels of phospho-JNK (P-JNK, p54 and p46) and phospho-c-Jun (P-c-Jun). Total levels of JNK and Ga12
expression, along with a-tubulin as a loading control, are also shown. Each panel shows the results of a single experiment that is representative of
three or more independent experiments.
doi:10.1371/journal.pone.0026085.g001
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Similar to the expression of activated Ga12 in MDA-MB-231
cells, receptor-mediated stimulation of G12 signaling by treat-
ment with thrombin caused a reorganization of the actin
cytoskeleton and stress fiber formation compared to untreated
cells, and an increase in stress fiber formation when JNK
expression is knocked down (Figure 4C, panels c, f). Quantifica-
tion of the fluorescence intensities of rhodamine-phalloidin
staining in control versus JNK siRNA cells clearly shows that
stress fiber formation is increased when JNK expression is
knocked down (Figure 4D, panel a). Although Ga12QL-induced
stress fiber formation is also increased in cells treated with JNK
siRNA, the difference is only marginal compared to control cells,
likely because of strong and persistent stimulation of Rho-
mediated signaling by activated Ga12 even in control cells
(Figure 4D, panel b). Thrombin-treated cells in which JNK
expression is knocked down, however, showed a significant
increase in rhodamine-phalloidin staining compared to control
cells (Figure 4D, panel c). These findings reinforce the notion of
the existence of a feedback pathway from JNK back to Rho, such
that reduction of JNK expression leads to increased Rho
activation and therefore increased stress fiber assembly.
Thrombin signals via G12 to activate JNK in breast cancer
cells, and JNK is required for stimulated 4T1 cell invasion
We next sought to assess whether Ga12-induced phosphoryla-
tion of JNK occurred during receptor-mediated activation of G12
proteins, and whether JNK has a role in receptor-stimulated breast
cancer cell invasion. When 4T1 mouse mammary carcinoma cells
stably expressing p115RGS (regulator of G protein signaling
domain of p115RhoGEF, a construct used to block G12 signaling)
were implanted in the mammary fat pads of female mice, there
was a striking decrease in metastasis and increase in metastasis-free
survival of these mice compared to control mice bearing tumors in
which G12 signaling had not been blocked, suggesting that G12
promotes metastasis in mice by stimulating invasion from the
primary tumor [19]. Hence, we decided to examine the effect of
JNK activation on thrombin-mediated invasion in the 4T1 cells,
since we had relevant in vivo data for a critical role of G12 proteins
in metastatic progression of these cells.
Expression of p115RGS in the 4T1 mammary carcinoma cells
led to a significant (,75%) decrease in their ability to invade
Matrigel in response to thrombin stimulation in transwell invasion
assays (Figure 5A). Additionally, expression of p115RGS led to a
decrease in Ga12QL-induced JNK as well as c-Jun phosphory-
lation in 4T1 cells (data not shown), suggesting that JNK is
activated downstream of Rho. Hence, we determined if stimula-
tion of 4T1 cells with thrombin activates JNK via G12 signaling.
Treatment of 4T1 cells with thrombin did indeed lead to an
increase in JNK as well as c-Jun phosphorylation (Figure 5B).
Furthermore, expression of p115RGS in these cells significantly
inhibited the phosphorylation of JNK and c-Jun in response to
thrombin stimulation (Figure 5B). Finally, siRNA-mediated
silencing of JNK expression significantly impaired stimulated
invasion of 4T1 cells (Figure 5C). Taken together, our data
indicates that JNK is activated downstream of receptor-mediated
G12 signaling via Rho, and JNK activation is required for
receptor-mediated 4T1 cell invasion.
Discussion
In this paper, we demonstrate that activation of JNK is required
for breast cancer cell invasion promoted by G12 signaling. We
observe that Ga12-induced activation of JNK is accompanied by
an increase in phosphorylation of c-Jun (a member of the AP-1
family of transcription factors) which is known to enhance its
transcriptional activity and regulate the transcription of cell-
invasion associated genes. In addition, we observe that JNK
activation is required for thrombin-induced cell invasion, and JNK
is likely activated downstream of G12 signaling via Rho since
blocking G12 signaling by expression of p115RGS significantly
decreases the level of JNK activation in 4T1 mammary carcinoma
cells.
Activation of Rho is a critical component in the ability of G12
proteins to promote invasion of breast cancer cells [19]. In the
current study, we demonstrate that JNK is activated downstream
Figure 2. Ga12QL promotes cell invasion through activation of
JNK. MDA-MB-231 cells were infected with GFP (control) or Ga12QL
adenovirus for 6–7 h and starved for ,20 h. (A) Cells were pre-treated
for 2 h with JNK inhibitor SP600125 (20 mM) and allowed to invade
Matrigel for 24 h, in the presence of the inhibitor or vehicle control, in a
transwell invasion assay (see Materials and Methods). (B) Cells were
transfected with JNK siRNA or control (luc) siRNA for ,72 h before
being infected with adenovirus. Cells expressing Ga12QL or GFP were
allowed to invade Matrigel for 24 h. For both panels, the invasion assay
was set up towards 5 mg/ml fibronectin. Cells that invaded were stained
and counted in four random optical fields for each transwell, with three
transwells per condition. Results are expressed as fold change in
invasion compared to vehicle-treated GFP control cells. The insets show
immunoblot analysis of the levels of Ga12, JNK and a-tubulin (loading
control). Data is presented as mean 6 SE from a single experiment that
is representative of three independent experiments. ** p,0.01 and
*** p,0.001, as determined by one-way ANOVA, followed by Tukey’s
multiple comparison test to obtain p values.
doi:10.1371/journal.pone.0026085.g002
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of Rho and ROCK since expression of dominant-negative RhoA
or treatment of cells with the ROCK inhibitor significantly
reduces the level of JNK phosphorylation induced by activated
Ga12. ROCK inhibitor treatment also decreases Ga12-induced
invasion, which would be expected if ROCK signals upstream of
JNK. Activated Rho is known to regulate the transcription factor
SRF via its ability to induce actin polymerization by a ROCK-
LIMK-cofilin pathway [31,37], and G12 signaling via Rho has
been shown to lead to transcriptional activation of c-fos SRE and
neoplastic transformation in fibroblasts [38]. Treatment of
MDA-MB-231 cells with the ROCK inhibitor blocks G12-
induced cell rounding and stress fiber formation (data not
shown), whereas knockdown of JNK expression does not
(Figure 4C). Therefore, G12 may be stimulating two parallel
pathways downstream of ROCK, one regulating actin polymer-
ization and the other leading to JNK activation, both
culminating in AP-1 transcriptional activity to promote invasion
of breast cancer cells.
Blockade of G12 signaling by p115RGS inhibits thrombin-
stimulated invasion of MDA-MB-231 cells [19]. Interestingly, in the
current study we found that p115RGS expression does not impact
on thrombin-stimulated JNK activation in these cells (data not
shown). Of note in this regard is that all G12-coupled receptors
characterized thus far also activate one or more other G protein
subfamilies, most notably Gq proteins [29]. Since the G12-coupled
receptor PAR-1 (protease-activated receptor-1), which is activated
by thrombin, has also been shown to stimulate Gq signaling, we
determined the effect of blocking Gq signaling, by expression of
Figure 3. Ga12QL activates a ROCK-JNK signaling axis. MDA-MB-231 cells were infected with adenovirus harboring GFP (control), Ga12QL or
dominant-negative RhoA (DN RhoA) for 6–7 h. (A) Cells were starved and treated with 1 U/ml thrombin for 10 min, as indicated, before lysis in JNK
activation buffer. Equal amounts of total protein in lysates were subjected to SDS-PAGE and immunoblot analysis to assess levels of phospho-JNK (P-
JNK, p54 and p46) and phospho-c-Jun (P-c-Jun). Total level of JNK expression, along with Rho GDI as a loading control, is also shown. (B) Cells were
starved and treated with ROCK inhibitor Y-27632 (10 mM) for 2 h before lysis in JNK activation buffer. Equal amounts of total protein in lysates were
subjected to SDS-PAGE and immunoblot analysis to assess levels of phospho-JNK (P-JNK, p54 and p46) and phospho-c-Jun (P-c-Jun). Total levels of
JNK and Ga12 expression, along with a-tubulin as a loading control, are also shown. Data shown in (A) and (B) are from a single experiment that is
representative of three independent experiments. (C) Cells infected with GFP or Ga12QL adenovirus were starved for ,18 h, then pre-treated with Y-
27632 (10 mM) for 2 h and allowed to invade Matrigel for 24 h in the presence of the inhibitor, towards 5 mg/ml fibronectin. Cells that invaded were
stained and counted in four random optical fields for each transwell, with three transwells per condition. Results are expressed as fold change in
invasion compared to vehicle-treated GFP control cells. The inset shows immunoblot analysis of Ga12 and a-tubulin (loading control) levels. Data is
presented as mean 6 SE from a single experiment that is representative of three independent experiments. *** p,0.001, as determined by one-way
ANOVA, followed by Tukey’s multiple comparison test to obtain p values.
doi:10.1371/journal.pone.0026085.g003
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Figure 4. ROCK and JNK signal downstream of Ga12QL-activated Rho. (A) MDA-MB-231 cells were transfected with control (luc) siRNA or
JNK siRNA for 3 days prior to infection with GFP (control) or Ga12QL adenovirus for 6–7 h. Cells were starved for ,18 h and lysed. Lysates were
subjected to pull-down assays using a GST fusion construct of the activated RhoA-binding domain of rhotekin, and levels of precipitated Rho-GTP
were determined by immunoblot analysis using anti-RhoA antibody. Total levels of RhoA, Ga12 and JNK in the lysates are also shown. (B) The data in
the anti-Rho immunoblots shown in (A) was quantified by plotting the intensities as percentage of activated Rho to total Rho for each sample. (C)
MDA-MB-231 cells were plated on coverslips and transfected with siRNA as stated above, prior to infection with GFP (control) (panels a, d) or Ga12QL
(panels b, e) adenovirus. Cells were starved for ,18 h, and those in two conditions (panels c, f) treated with 1 U/ml thrombin for 10 min as indicated
before all cells were fixed and stained with rhodamine-phalloidin to visualize actin (see Materials and Methods). Representative images for each
condition are shown. Bar, 50 mM. Each panel shows the results of a single experiment that is representative of three independent experiments. (D)
Fluorescence intensities of rhodamine-phalloidin staining were quantified using MetaMorph 7.5 software. Average fluorescence intensities are
plotted as mean 6 SE for data from two slides imaged with the same exposure time for every condition shown; ,220 cells (panels a, c), and ,120
cells (panel b) quantified per slide.
doi:10.1371/journal.pone.0026085.g004
JNK and G12-Induced Invasion
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RGS2, on JNK activation. RGS2 expression did not affect
thrombin-induced JNK or c-Jun activation in either MDA-MB-
231 cells or 4T1 cells (data not shown). Thus, while it appears that
there are multiple pathways stimulated by thrombin that lead to
JNK activation in MDA-MB-231 cells, thrombin-induced activation
of JNK is predominantly mediated by G12 signaling in the 4T1 cells.
Cancer cell invasion is a complex phenomenon that involves
interactions with the extracellular matrix and migration of cells.
The changes in cytoskeletal dynamics required for cell migration
are coordinated primarily by Rho GTPases [39,40]. Interestingly,
we observe a higher level of Ga12QL-activated Rho and increased
stress fiber formation in JNK siRNA-treated cells versus control
cells (Figure 4). This suggests the possible existence of a feedback
pathway where by knocking down JNK expression leads to more
Rho activation. Several studies have shown that the level of
activated Rho appears to be critical during cell migration [41,42],
and in neutrophils excessive Rho activation mediated by
constitutively-active Ga12/13 has been shown to inhibit polari-
zation and motility [43]. In addition to regulating the level of
activated Rho, JNK may be playing a role in the spatiotemporal
control of Rho function to promote cell invasion. In this context,
Ga13, and to a lesser extent Ga12, have been shown to interact
with the JNK-interacting leucine zipper protein (JLP), a scaffolding
protein involved in assembling the JNK signaling module
including upstream MAPK kinase kinases and MAPK kinases
that activate JNK and its downstream transcription factors [44–
46]. It is interesting to note that microarray analysis of primary
epithelial cell populations from nasopharyngeal biopsies showed
an upregulation of several genes on the G12 signaling pathway
including RhoA and JNK [47].
In conclusion, we have shown that JNK is an important player
in the invasion of breast cancer cells promoted by G12 signaling,
and that it is activated downstream of Rho and ROCK. The study
also hints at an intriguing feedback loop between JNK activity and
Rho activation. These findings further our understanding of the
biology of breast cancer metastasis and implicate JNK as a
potential therapeutic target.
Acknowledgments
We thank Tohru Kozasa, Robert Lefkowitz, Fred Miller and Terete Borra´s
for providing reagents, Patrick Kelly for advice and insightful discussions,
and Michelle Kimple for critical review of this manuscript. Fluorescence
imaging data was collected and analyzed in the Duke University Light
Microscopy Core Facility.
Author Contributions
Conceived and designed the experiments: JJ IC PJC. Performed the
experiments: JJ IC. Analyzed the data: JJ IC. Contributed reagents/
materials/analysis tools: JJ IC PJC. Wrote the paper: JJ.
Figure 5. JNK is activated downstream of G12 signaling in 4T1
mammary carcinoma cells and is required for cell invasion. (A)
4T1 cells were infected with adenovirus harboring GFP (control) or the
RGS domain of p115RhoGEF (p115RGS) for ,20 h, and then starved for
8 h. Cells were allowed to invade Matrigel for 24 h in the presence of
thrombin (1 U/ml), towards 3% FBS. Cells that invaded were stained and
counted in four random optical fields for each transwell, with three
transwells per condition. Results are shown as percent invasion
compared to invasion in the control cells. The inset shows p115RGS
expression. Data is presented as mean 6 SE from a single experiment
that is representative of three independent experiments. * p,0.05 as
determined by one-way ANOVA, followed by Tukey’s multiple
comparison test to obtain p values. (B) 4T1 cells were infected with
adenovirus harboring GFP (control) or p115RGS, as indicated, for ,18–
19 h and starved for ,9 h. Cells were then treated with 1 U/ml
thrombin for 10 min, as indicated, before lysis in JNK activation buffer.
Equal amounts of total protein in the lysates were separated by SDS-
PAGE and immunoblot analysis was performed to assess levels of
phospho-JNK (P-JNK, p54 and p46) and phospho-c-Jun (P-c-Jun). Total
levels of JNK, myc-p115RGS and RhoGDI (loading control) are also
shown. Data shown are from a single experiment that is representative
of three independent experiments. (C) 4T1 cells were transfected with
control (luc) and JNK siRNA for 67–68 h, and then starved for 8 h. Cells
were allowed to invade Matrigel for 24 h in the presence of thrombin,
towards 3% FBS. Cells that invaded were quantified as detailed for
panel A. Results are shown as percent invasion compared to invasion in
the control cells. The inset shows immunoblot analysis of JNK and Rho
GDI (loading control) levels. Data is presented as mean 6 SE from a
single experiment that is representative of three independent
experiments. ** p,0.01 as determined by one-way ANOVA, followed
by Tukey’s multiple comparison test.
doi:10.1371/journal.pone.0026085.g005
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